Skip to main content
OpenTrials
Completed

NCT Number: NCT04083547

Circulating Tumour Cells in Patients With Peritoneal Metastases

This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Akademiska Sjukhuset (Uppsala University hospital)

Uppsala, 75185, Sweden

About this study

CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Peritoneal metastases being treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Exclusion criteria

  • None

Treatment and study plan

iCellate

Diagnostic Test

New method of circulating tumour cell detection and capture.

Primary outcomes

  1. Prognostic value

    Time frame: 2 year.

    Prediction of survival and recurrence according to the occurrence of CTCs.

Sponsors and collaborators

Lead sponsor

Uppsala University

Other

Registry information

Official study title

Cirkulerande Tumörceller Hos Patienter Med Bukhinnespridda tumörer

Important dates

Study start
2017
Primary completion
2019
Study completion
2020
First posted
Sep 10, 2019
Registry last updated
Nov 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.